1173 related articles for article (PubMed ID: 28082369)
1. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
2. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
Eramo MJ; Mitchell CA
Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
[TBL] [Abstract][Full Text] [Related]
4. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
5. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
6. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.
Ooms LM; Fedele CG; Astle MV; Ivetac I; Cheung V; Pearson RB; Layton MJ; Forrai A; Nandurkar HH; Mitchell CA
Mol Biol Cell; 2006 Feb; 17(2):607-22. PubMed ID: 16280363
[TBL] [Abstract][Full Text] [Related]
7. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
8. AKT1 and PTEN show the highest affinities among phosphoinositide binding proteins for the second messengers PtdIns(3,4,5)P
Nelson N; Razeto A; Gilardi A; Grättinger M; Kirchmair J; Jücker M
Biochem Biophys Res Commun; 2021 Sep; 568():110-115. PubMed ID: 34214875
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
10. Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway.
Jethwa N; Chung GH; Lete MG; Alonso A; Byrne RD; Calleja V; Larijani B
J Cell Sci; 2015 Sep; 128(18):3456-65. PubMed ID: 26240177
[TBL] [Abstract][Full Text] [Related]
11. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.
Ivetac I; Munday AD; Kisseleva MV; Zhang XM; Luff S; Tiganis T; Whisstock JC; Rowe T; Majerus PW; Mitchell CA
Mol Biol Cell; 2005 May; 16(5):2218-33. PubMed ID: 15716355
[TBL] [Abstract][Full Text] [Related]
12. The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis.
Ooms LM; Binge LC; Davies EM; Rahman P; Conway JR; Gurung R; Ferguson DT; Papa A; Fedele CG; Vieusseux JL; Chai RC; Koentgen F; Price JT; Tiganis T; Timpson P; McLean CA; Mitchell CA
Cancer Cell; 2015 Aug; 28(2):155-69. PubMed ID: 26267533
[TBL] [Abstract][Full Text] [Related]
13. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets.
Banfić H; Tang X; Batty IH; Downes CP; Chen C; Rittenhouse SE
J Biol Chem; 1998 Jan; 273(1):13-6. PubMed ID: 9417038
[TBL] [Abstract][Full Text] [Related]
14. Sequential conversion of PtdIns3P to PtdIns(3,5)P
Rodgers SJ; Jones EI; Mitchell CA; McGrath MJ
Autophagy; 2023 Apr; 19(4):1365-1367. PubMed ID: 36103410
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
16. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
17. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1.
Currie RA; Walker KS; Gray A; Deak M; Casamayor A; Downes CP; Cohen P; Alessi DR; Lucocq J
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):575-83. PubMed ID: 9895304
[TBL] [Abstract][Full Text] [Related]
19. Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate.
Banfić H; Downes CP; Rittenhouse SE
J Biol Chem; 1998 May; 273(19):11630-7. PubMed ID: 9565582
[TBL] [Abstract][Full Text] [Related]
20. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
